Advertisement
Canada markets closed

  • S&P/TSX

    24,690.48
    +129.28 (+0.53%)
     

  • S&P 500

    5,841.47
    -1.00 (-0.02%)
     

  • DOW

    43,239.05
    +161.35 (+0.37%)
     

  • CAD/USD

    0.7250
    -0.0000 (-0.00%)
     

  • CRUDE OIL

    71.00
    +0.33 (+0.47%)
     

  • Bitcoin CAD

    93,913.74
    +903.87 (+0.97%)
     

  • XRP CAD

    0.75
    -0.00 (-0.40%)
     

  • GOLD FUTURES

    2,723.10
    +15.60 (+0.58%)
     

  • RUSSELL 2000

    2,280.85
    -5.82 (-0.25%)
     

  • 10-Yr Bond

    4.0960
    +0.0800 (+1.99%)
     

  • NASDAQ futures

    20,377.50
    +9.50 (+0.05%)
     

  • VOLATILITY

    19.11
    -0.47 (-2.40%)
     

  • FTSE

    8,385.13
    +56.06 (+0.67%)
     

  • NIKKEI 225

    39,058.32
    +147.13 (+0.38%)
     

  • CAD/EUR

    0.6687
    -0.0003 (-0.04%)
     

Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference

Business Wire
·1 min read

HERCULES, Calif., May 23, 2024--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 10:30 AM Eastern Time (7:30 AM Pacific Time).

A live webcast and subsequent replay of the event will be available in the Investor Relations section of Bio-Rad’s website at bio-rad.com.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 8,000 employees and $2.7 billion in revenues in 2023. Our customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240523594442/en/

Contacts

Investor Contact:
Edward Chung, Investor Relations
510-741-6104
ir@bio-rad.com

Media Contact:
Anna Gralinska, Corporate Communications
510-741-6643
cc@bio-rad.com